80 percent of cervical cancers found to be preventable with latest 9-valent HPV vaccine
The new 9-valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11- or 12-year-old children before they are exposed to the virus. The study also found the 9-Valent vaccine, under the trademark of Gardasil-9, has the potential to protect against an additional 8 percent of oropharyngeal cancers, which include the base of the tongue and tonsils. This disease is the second-most-common HPV-associated cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 11, 2015 Category: Science Source Type: news
80 percent of cervical cancers found to be preventable with latest 9-valent HPV vaccine
(Cedars-Sinai Medical Center) The new 9-valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11- or 12-year-old children before they are exposed to the virus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2015 Category: Cancer & Oncology Source Type: news
HPV: 1.1 Million More Women Started Vaccine After ACA PassedHPV: 1.1 Million More Women Started Vaccine After ACA Passed
The Affordable Care Act, which extended health coverage and erased copayments for preventive treatments, was associated with 1.1 million more young women initiating the human papillomavirus vaccine. Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - May 7, 2015 Category: OBGYN Tags: Hematology-Oncology News Source Type: news
Gardasil vaccination reduces cervical dysplasia in teen years
Vaccination with Gardasil, the quadrivalent human papillomavirus (HPV) vaccine, can reduce cervical dysplasia and genital warts as early as 14-17 years old, a recent study found.
“The fact that these benefits were observed in such a young age group strengthens current recommendations that... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 27, 2015 Category: Dermatology Tags: CME-candidate FPN News IMN News ONCR News ONCR Prevention & Epidemiology SAN Clinical News SAN News Source Type: news
HPV vaccine should not be delayed
(Queen's University) New research out of Queen's University shows early benefits from the human papillomavirus vaccine in young girls. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2015 Category: Global & Universal Source Type: news
By 2020, The Most Common HPV-Related Cancer Will Affect Men
While currently recommended for both boys and girls, the HPV vaccine was initially marketed -- and is still thought of -- as a way to protect young women and girls from cervical, vaginal and vulvar cancer. Boys, it's been commonly thought, should be vaccinated primarily to benefit herd immunity and any future female partners.
But a new analysis from researchers at the Princess Margaret Cancer Center in Toronto, Canada, points out that boys who get the vaccine receive important protection as well, not only against genital warts, but against HPV strains that cause oropharyngeal (mouth and throat) cancer.
"We believe this s...
Source: Science - The Huffington Post - April 20, 2015 Category: Science Source Type: news
Gardasil HPV 9 Vaccine Launched in CanadaGardasil HPV 9 Vaccine Launched in Canada
The new 9-valent version of the human papillomavirus (HPV) vaccine is now available in Canada. It is already available in the United States, and is close to approval in Europe. International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
US ACIP recommends Gardasil 9
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2015 Category: Drugs & Pharmacology Source Type: news
EU Recommends Approval of Gardasil 9 VaccineEU Recommends Approval of Gardasil 9 Vaccine
The new Gardasil 9 vaccine, which offers protection against nine types of human papillomavirus, has been recommended for approval in Europe. News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
ACIP Publishes Recommendations for Nine-Valent HPV Vaccine (FREE)
By Kelly Young
Edited by André Sofair, MD, MPH
The CDC's Advisory Committee on Immunization Practices has published its recommendations for vaccinating against human papillomavirus with the nine-valent HPV vaccine (Gardasil 9) in MMWR.The nine-valent vaccine targets five more strains than the quadrivalent version, and these five strains (31, 33, 45, 52, and 58) … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 27, 2015 Category: Primary Care Source Type: news
Well: A New Vaccine Targets More HPV Strains
A new vaccine protects against more forms of the cancer-causing human papillomavirus than the existing HPV vaccine, new research shows. (Source: NYT)
Source: NYT - March 2, 2015 Category: American Health Authors: By NICHOLAS BAKALAR Tags: Healthy Consumer Sexually Transmitted Diseases Gardasil (Vaccine) Featured Vaccination and Immunization Human Papillomavirus (HPV) Source Type: news
Well: A New Vaccine Targets More HPV Strains
A new vaccine protects against more forms of the cancer-causing human papillomavirus than the existing HPV vaccine, new research shows. (Source: NYT Health)
Source: NYT Health - March 2, 2015 Category: Consumer Health News Authors: By NICHOLAS BAKALAR Tags: Healthy Consumer Sexually Transmitted Diseases Gardasil (Vaccine) Featured Vaccination and Immunization Human Papillomavirus (HPV) Source Type: news
Well: A New Vaccine Targets More HPV Strains
A new vaccine protects against more forms of the cancer-causing human papillomavirus than the existing HPV vaccine, new research shows. (Source: NYT)
Source: NYT - March 2, 2015 Category: Nutrition Authors: By NICHOLAS BAKALAR Tags: Healthy Consumer Sexually Transmitted Diseases Gardasil (Vaccine) Featured Vaccination and Immunization Human Papillomavirus (HPV) Source Type: news
CDC Advisers Recommend Adding Gardasil 9 to HPV Vaccine Schedule (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
The CDC's Advisory Committee on Immunization Practices has recommended that the nine-valent human papillomavirus … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 2, 2015 Category: Primary Care Source Type: news
Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that the U.S. Centers for Disease Control and
Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP)
voted to include GARDASIL®9 (Human Papillomavirus 9-valent
Vaccine, Recombinant) in the recommendations for use of HPV vaccines.
GARDASIL 9 has been added to the routine recommendations for vaccination
of 11- and 12- year-old females and males. The vacci...
Source: Merck.com - Corporate News - February 26, 2015 Category: Pharmaceuticals Tags: Vaccine News Corporate News Latest News Source Type: news
